Clobazam 20 mg/1 (Clobazam TABLET) 20 mg/1

Clobazam 20 mg tablets are a benzodiazepine medication used for managing certain types of seizures. This oral medication is manufactured by Camber Pharmaceuticals, Inc. in the USA.

Strength

20 mg/1

Pack Size

100 TABLET in 1 BOTTLE (31722-640-01)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clobazam is primarily used as an adjunctive treatment for seizures, particularly in conditions like Lennox-Gastaut syndrome. It works by enhancing the effects of a natural chemical in the brain to calm abnormal electrical activity. People often ask, 'What is Clobazam used for?' and the answer typically involves its role in seizure management.

Side Effects

Common effects of Clobazam may include drowsiness, dizziness, and fatigue. Some users also report experiencing sedation and coordination issues. These effects can vary from person to person and may diminish over time.

Precautions & Warnings

Clobazam should be handled with care, especially by individuals with a history of substance abuse or respiratory issues. It is important to follow the advice of a healthcare provider regarding its use. Always store Clobazam in a safe place away from children and pets.

Avoid Interactions

Clobazam may interact with other medications, including alcohol, antidepressants, and other central nervous system depressants. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Clobazam is commonly used as an adjunctive treatment for seizures, particularly in conditions like Lennox-Gastaut syndrome.

Clobazam is typically taken orally, as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions.

Common side effects of Clobazam may include drowsiness, dizziness, and fatigue. Some users also report experiencing sedation and coordination issues.

Clobazam may interact with other medications, including alcohol and central nervous system depressants. It is advisable to discuss all current medications with a healthcare provider.

The safety of Clobazam for long-term use should be discussed with a healthcare provider, who can provide guidance based on individual health conditions and needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.